In support of our finding are two previous reports that a CAPS mouse transgenic model carrying human NLRP3 pathogenic mutations maintain homeostasis in the gut microbiota and are resistant to experimental colitis (19), whereas NLRP12 defect results in microbiome disturbance and colitis (20). The gene discussed is NLRP12; the disease is colitis.